Key result
Endothelin-1 activates extracellular signal-regulated protein kinases and induces cardiomyocyte hypertrophy through protein kinase C and Raf-1 kinase pathways, independent of Src or Ras.
Why the study?
Does endothelin-1 induce ERK activation in cultured neonatal rat cardiomyocytes through protein kinase C, Src, Ras, or Raf-1 kinase pathways?
Does endothelin-1 induce ERK activation in cultured neonatal rat cardiomyocytes through protein kinase C, Src, Ras, or Raf-1 kinase pathways?
Endothelin-1 induces hypertrophic responses in cardiomyocytes via protein kinase C and Raf-1 kinase pathways, independent of Src and Ras.
Answers are grounded in this paper and cite their sources.
May guide hypertrophy pathway research; leaves open translation to human cardiac remodeling.
We have previously shown that endothelin-1 (ET-1) modulates mechanical stretch-induced hypertrophic responses such as extracellular signal-regulated protein kinase (ERK) activation in cardiac myocytes. This study was undertaken to elucidate the ET-1-evoked signal transduction pathways leading to ERK activation. ET-1 was added to cultured cardiac myocytes of neonatal rats with or without a variety of inhibitors. ET-1 activated ERKs, which were followed by an increase in protein synthesis, and inhibition of protein kinase C activities by calphostin C completely suppressed the ET-1-induced ERK activation. We next examined whether tyrosine kinases or Ras are involved in ET-1-induced signaling pathways in cardiomyocytes. Pretreatment with a receptor tyrosine kinase inhibitor did not attenuate ET-1-induced activation of ERKs. Also, co-transfection of the dominant-negative mutant of Ras or active mutant of C-terminal Src kinase, a tyrosine kinase which inhibits Src family tyrosine kinases, with hemagglutinin-tagged ERK2 had no effects on ET-1-induced ERK2 activation. On the other hand, blockade of Raf-1 kinase function by overexpression of the dominant-negative mutant of Raf-1 kinase completely inhibited ET-1-induced ERK2 activation. These results suggest that protein kinase C and Raf-1 kinase, but not Src or Ras, are critical to ET-1-induced ERK activation in cardiac myocytes.
No takes yet. Share an insight, caveat, or question.
Yamazaki et al. (1999) studied Cardiac hypertrophy (in vitro). Endothelin-1 (ET-1) vs. Control (no stimulus) was evaluated on Protein synthesis (amino acid incorporation) and ERK activation (p=<0.05). Endothelin-1 activates extracellular signal-regulated protein kinases and induces cardiomyocyte hypertrophy through protein kinase C and Raf-1 kinase pathways, independent of Src or Ras.
Synapse has enriched 10 related papers. Consider them for comparative context: